SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Orexo AB (publ) (ORXOF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 17/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ORXOF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio3.05
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-3.74
Book Value / Share$0.00
Revenue / Share$0.75
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.84 |
$705.8M |
$29M |
4.1% |
| 2017 |
$0.67 |
$643.7M |
$23.2M |
3.6% |
| 2018 |
$3.93 |
$783.1M |
$137.9M |
17.6% |
| 2019 |
$6.20 |
$844.8M |
$219.1M |
25.9% |
| 2020 |
$-2.45 |
$663.6M |
$-84.4M |
-12.7% |
| 2021 |
$-6.51 |
$565M |
$-223.5M |
-39.6% |
| 2022 |
$-5.17 |
$624.3M |
$-177.6M |
-28.4% |
| 2023 |
$-3.73 |
$638.8M |
$-128.3M |
-20.1% |
| 2024 |
$-5.89 |
$590M |
$-203M |
-34.4% |
| 2025 |
$-3.74 |
$25.93M |
$-129.47M |
-499.2% |
